R. Hotchkiss and I. Karl, The Pathophysiology and Treatment of Sepsis, New England Journal of Medicine, vol.348, issue.2, pp.138-150, 2003.
DOI : 10.1056/NEJMra021333

V. Dombrovskiy, A. Martin, J. Sunderram, and H. Paz, Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003*, Critical Care Medicine, vol.35, issue.5, pp.1244-1250, 1993.
DOI : 10.1097/01.CCM.0000261890.41311.E9

D. Angus, W. Linde-zwirble, J. Lidicker, G. Clermont, J. Carcillo et al., Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care, Critical Care Medicine, vol.29, issue.7, pp.1303-1310, 2001.
DOI : 10.1097/00003246-200107000-00002

J. Vincent, Y. Sakr, C. Sprung, V. Ranieri, K. Reinhart et al., Sepsis in European intensive care units: Results of the SOAP study*, Critical Care Medicine, vol.34, issue.2, pp.344-353, 2006.
DOI : 10.1097/01.CCM.0000194725.48928.3A

R. Munford and J. Pugin, Normal Responses to Injury Prevent Systemic Inflammation and Can Be Immunosuppressive, American Journal of Respiratory and Critical Care Medicine, vol.163, issue.2, pp.316-321, 2001.
DOI : 10.1164/ajrccm.163.2.2007102

G. Monneret, F. Venet, A. Pachot, and A. Lepape, Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony, Mol Med, vol.14, pp.64-78, 2008.

J. Cavaillon and M. Adib-conquy, Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis, Critical Care, vol.10, issue.5, p.233, 2006.
DOI : 10.1186/cc5055

R. Hotchkiss, K. Tinsley, P. Swanson, R. Schmieg, . Jr et al., Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans, The Journal of Immunology, vol.166, issue.11, pp.6952-6963, 2001.
DOI : 10.4049/jimmunol.166.11.6952

F. Venet, C. Chung, H. Kherouf, A. Geeraert, C. Malcus et al., Increased circulating regulatory T cells (CD4+CD25+CD127???) contribute to lymphocyte anergy in septic shock patients, Intensive Care Medicine, vol.71, issue.4, pp.678-686, 2009.
DOI : 10.1007/s00134-008-1337-8

G. Monneret, A. Lepape, N. Voirin, J. Bohe, F. Venet et al., Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock, Intensive Care Medicine, vol.51, issue.8, pp.1175-1183, 2006.
DOI : 10.1007/s00134-006-0204-8

URL : https://hal.archives-ouvertes.fr/hal-00428008

M. Keir, M. Butte, G. Freeman, and A. Sharpe, PD-1 and Its Ligands in Tolerance and Immunity, Annual Review of Immunology, vol.26, issue.1, pp.677-704, 2008.
DOI : 10.1146/annurev.immunol.26.021607.090331

C. Day, D. Kaufmann, P. Kiepiela, J. Brown, E. Moodley et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, vol.170, issue.7109, pp.350-354, 2006.
DOI : 10.1126/science.274.5284.94

L. Trautmann, L. Janbazian, N. Chomont, E. Said, S. Gimmig et al., Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction, Nature Medicine, vol.168, issue.10, pp.1198-1202, 2006.
DOI : 10.1038/nm1482

C. Petrovas, J. Casazza, J. Brenchley, D. Price, E. Gostick et al., T cell survival in HIV infection, The Journal of Experimental Medicine, vol.105, issue.10, pp.2281-2292, 2006.
DOI : 10.1074/jbc.M300633200

X. Huang, F. Venet, Y. Wang, A. Lepape, Z. Yuan et al., PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis, Proceedings of the National Academy of Sciences, vol.106, issue.15, pp.6303-6308, 2009.
DOI : 10.1073/pnas.0809422106

R. Bone, Toward an Epidemiology and Natural History of SIRS (Systemic Inflammatory Response Syndrome), JAMA: The Journal of the American Medical Association, vol.268, issue.24, pp.3452-3455, 1992.
DOI : 10.1001/jama.1992.03490240060037

C. Landelle, A. Lepape, A. Francais, E. Tognet, H. Thizy et al., Conclusions., Infection Control & Hospital Epidemiology, vol.130, issue.11, pp.1054-1065, 2008.
DOI : 10.1097/01.CCM.0000050298.59549.4A

G. Monneret, N. Elmenkouri, J. Bohe, A. Debard, M. Gutowski et al., Analytical requirements for measuring monocytic human lymphocyte antigen DR by flow cytometry: application to the monitoring of patients with septic shock, Clin Chem, vol.48, pp.1589-1592, 2002.

G. Monneret, M. Finck, F. Venet, A. Debard, J. Bohe et al., The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration, Immunology Letters, vol.95, issue.2, pp.193-198, 2004.
DOI : 10.1016/j.imlet.2004.07.009

E. Said, F. Dupuy, L. Trautmann, Y. Zhang, Y. Shi et al., Programmed death-1???induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection, Nature Medicine, vol.372, issue.10, pp.452-459, 2010.
DOI : 10.1038/nm.2106

Y. Latchman, C. Wood, T. Chernova, D. Chaudhary, M. Borde et al., PD-L2 is a second ligand for PD-1 and inhibits T cell activation, Nature Immunology, vol.137, issue.3, pp.261-268, 2001.
DOI : 10.1038/85330

L. Carter, L. Fouser, J. Jussif, L. Fitz, B. Deng et al., PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2, European Journal of Immunology, vol.32, issue.3, pp.634-643, 2002.
DOI : 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9

G. Freeman, A. Long, Y. Iwai, K. Bourque, T. Chernova et al., Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation, The Journal of Experimental Medicine, vol.142, issue.7, pp.1027-1034, 2000.
DOI : 10.1016/0008-8749(91)90091-O

J. Chemnitz, R. Parry, K. Nichols, C. June, and J. Riley, SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation, The Journal of Immunology, vol.173, issue.2, pp.945-954, 2004.
DOI : 10.4049/jimmunol.173.2.945

L. Golden-mason, B. Palmer, J. Klarquist, J. Mengshol, N. Castelblanco et al., Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction, Journal of Virology, vol.81, issue.17, pp.9249-9258, 2007.
DOI : 10.1128/JVI.00409-07

N. Nakamoto, D. Kaplan, J. Coleclough, Y. Li, M. Valiga et al., Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization, Gastroenterology, vol.134, issue.7, pp.1927-1937, 1937.
DOI : 10.1053/j.gastro.2008.02.033

J. Zhang, Z. Zhang, X. Wang, J. Fu, J. Yao et al., PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors, Blood, vol.109, issue.11, pp.4671-4678, 2007.
DOI : 10.1182/blood-2006-09-044826

Y. Zhang, J. Li, J. Lou, Y. Zhou, L. Bo et al., Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients, Critical Care, vol.15, issue.1, p.70, 2011.
DOI : 10.1097/CCM.0b013e3181ab858a

G. Peng, S. Li, W. Wu, X. Tan, Y. Chen et al., PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients, Molecular Immunology, vol.45, issue.4, pp.963-970, 2008.
DOI : 10.1016/j.molimm.2007.07.038

Y. Zhang, Y. Zhou, J. Lou, J. Li, L. Bo et al., PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction, Critical Care, vol.14, issue.6, p.220, 2010.
DOI : 10.1186/cc9354

G. Bandyopadhyay, A. De, K. Laudanski, F. Li, C. Lentz et al., Negative signaling contributes to T-cell anergy in trauma patients, Critical Care Medicine, vol.35, issue.3, pp.794-801, 2007.
DOI : 10.1097/01.CCM.0000256847.61085.A5

. Guignant, Critical Care, p.99, 2011.

K. Laudanski, C. Miller-graziano, X. W. Mindrinos, M. Richards, D. De et al., Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways, Proceedings of the National Academy of Sciences, vol.103, issue.42, pp.15564-15569, 2006.
DOI : 10.1073/pnas.0607028103

Y. Sun, N. Brown, M. Ruddy, M. Miller, Y. Lee et al., B and T Lymphocyte Attenuator Tempers Early Infection Immunity, The Journal of Immunology, vol.183, issue.3, pp.1946-1951, 2009.
DOI : 10.4049/jimmunol.0801866

F. Venet, J. Bohe, A. Debard, J. Bienvenu, A. Lepape et al., Both percentage of ???? T lymphocytes and CD3 expression are reduced during septic shock, Critical Care Medicine, vol.33, issue.12, pp.2836-2840, 2005.
DOI : 10.1097/01.CCM.0000189745.66585.AE

C. Hinrichs, K. Kotsch, S. Buchwald, M. Habicher, N. Saak et al., Perioperative Gene Expression Analysis for Prediction of Postoperative Sepsis, Clinical Chemistry, vol.56, issue.4, pp.613-622, 2010.
DOI : 10.1373/clinchem.2009.133876

A. De, K. Kodys, J. Pellegrini, B. Yeh, R. Furse et al., Induction of Global Anergy Rather Than Inhibitory Th2 Lymphokines Mediates Posttrauma T Cell Immunodepression, Clinical Immunology, vol.96, issue.1, pp.52-66, 2000.
DOI : 10.1006/clim.2000.4879

R. Hotchkiss and S. Opal, Immunotherapy for Sepsis ??? A New Approach against an Ancient Foe, New England Journal of Medicine, vol.363, issue.1, pp.87-89, 2010.
DOI : 10.1056/NEJMcibr1004371

Y. Ishida, Y. Agata, K. Shibahara, and T. Honjo, Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death, EMBO J, vol.11, pp.3887-3895, 1992.

P. Brahmamdam, S. Inoue, J. Unsinger, K. Chang, J. Mcdunn et al., Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis, Journal of Leukocyte Biology, vol.88, issue.2, pp.233-240, 2010.
DOI : 10.1189/jlb.0110037

F. Turrel-davin, C. Guignant, A. Lepape, B. Mougin, G. Monneret et al., Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients, Critical Care, vol.14, issue.4, p.133, 2010.
DOI : 10.1186/cc9181

S. Goyert and J. Silver, Editorial: PD-1, a new target for sepsis treatment: better late than never, Journal of Leukocyte Biology, vol.88, issue.2, pp.225-226, 2010.
DOI : 10.1189/jlb.0410240